The Patent Finder

Brightpath Biotherapeutics Co., Ltd.

Also on record
Records under this name other than the patents Brightpath Biotherapeutics Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Brightpath Biotherapeutics Co., Ltd.

PatentTitleStatus Expires Confidence
US 9,642,900CTL inducer composition
Lapsed on the fee record
Ended May 9, 2025 · From the USPTO record
Lapsed on the fee recordEnded May 9, 2025From the USPTO record
US 7,655,751Epidermal growth factor receptor-derived peptides
Term ended
Term ended Mar 13, 2025 · From the USPTO record
Term endedTerm ended Mar 13, 2025From the USPTO record
US 9,505,824Antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation
Lapsed on the fee record
Ended Nov 29, 2024 · From the USPTO record
Lapsed on the fee recordEnded Nov 29, 2024From the USPTO record
US 9,102,715CTL inducer composition
Lapsed on the fee record
Ended Aug 11, 2023 · From the USPTO record
Lapsed on the fee recordEnded Aug 11, 2023From the USPTO record
US 7,465,452Tumor antigen
Term ended
Term ended Sep 27, 2022 · From the USPTO record
Term endedTerm ended Sep 27, 2022From the USPTO record
US 7,148,326Tumor Antigen
Term ended
Term ended Aug 31, 2022 · High confidence
Term endedTerm ended Aug 31, 2022High confidence
US 7,524,930Tumor Antigen
Term ended
Term ended Apr 7, 2022 · High confidence
Term endedTerm ended Apr 7, 2022High confidence
US 7,404,270Tumor Antigen
Term ended
Term ended Jul 30, 2021 · High confidence
Term endedTerm ended Jul 30, 2021High confidence
US 7,408,037Tumor Antigen
Term ended
Term ended Jul 30, 2021 · High confidence
Term endedTerm ended Jul 30, 2021High confidence
US 7,427,660Tumor Antigen
Term ended
Term ended Jul 30, 2021 · High confidence
Term endedTerm ended Jul 30, 2021High confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited